ArticleCancer immunology, immunotherapy : CII2014

Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Jungsun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.